FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 for a later inspection.
483 Nostrum Labs Jan 2001

483 Nostrum Labs Jan 2001

Shirley Berryman FDA, Brenda Hamilton FDA$595.00 - Available Now

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 19 Jan 2001.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Jan 2001
  • Location: Kansas City, United States
  • FEI: 1930436
Add To Cart